Received Aug 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 33FD3 | — |
Shingrix vaccine received at the age of 24; Shingrix administered instead of varicella vaccine; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 24-year-old female patient who received Herpes zoster (Shingrix) (batch number 33FD3, expiry date 30-JAN-2027) for prophylaxis. Co-suspect products included VARICELLA ZOSTER VACCINE (VARICELLA VACCINE) for prophylaxis. On 04-AUG-2025, the patient received Shingrix. The patient did not receive VARICELLA VACCINE. On 04-AUG-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Shingrix vaccine received at the age of 24) and wrong vaccine administered (Verbatim: Shingrix administered instead of varicella vaccine). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were not applicable. Additional Information: GSK Receipt Date 06-AUG-2025 Licensed Practical Nurse explained that a 24-year-old patient who was not immunocompromised came for a varicella vaccine and a healthcare provider thought Shingrix might be used for varicella and administered it , which led to wrong vaccine administered. Patient received Shingrix vaccine below the recommended age schedule, which led to inappropriate age at vaccine administration.